Jennifer Skiles
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.4% of the total across 73 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Mayne Pharma Commercial LLC at 24.7% of the total. Reporting peaked in 2021 at $559 and has fallen 55.2% since, to $250 in 2025.
Across 73 payments — averaging $24.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mayne Pharma Commercial LLC$441
- AbbVie$229
- Sage Therapeutics, LLC$158
- Shield Therapeutics Inc$145
- Myriad Women's Health, Inc.$136
- Astellas Pharma US Inc$134
- plus $543 from 15 others
What the payments were for
- Food & beverage$1,66693%
- Education$1006%
- Gifts$191%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mayne Pharma Commercial LLC | 9 | $441 |
| AbbVie | 13 | $229 |
| Sage Therapeutics, LLC | 10 | $158 |
| Shield Therapeutics Inc | 6 | $145 |
| Myriad Women's Health, Inc. | 1 | $136 |
| Astellas Pharma US Inc | 2 | $134 |
| Abiomed | 4 | $77 |
| Exeltis, USA Inc. | 3 | $51 |
| Avion Pharmaceuticals | 3 | $49 |
| Therapeuticsmd, Inc. | 3 | $46 |
| Myovant Sciences Inc. | 2 | $43 |
| Bayer | 2 | $43 |
| Lupin Inc. | 3 | $42 |
| Exact Sciences | 2 | $39 |
| Axonics, Inc. | 2 | $37 |
| Pfizer | 2 | $30 |
| Organon | 2 | $27 |
| Evofem Biosciences, Inc. | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
| Mission Pharmacal Company | 1 | $13 |
| AMAG Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- myRisk$136
How this compares
$1,785 in reported general payments places this provider in the 75th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ZafemyNorelgestromin/Ethin.Estradiol | 14 | $1,524 |
Paid to pharmacies, not to this prescriber.
Other family in Tyler
- Machelle McDowellTyler$103K
- Jonathan KingTyler$97K
- Kirsten StuberTyler$79K
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.